Figure 4K)
Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs
"Not everyone who is interested in these medications should necessarily be prescribed one." Despite the drug's many benefits, which include reducing the risk of major cardiac events, stroke and early death, Brady, the Ontario pharmacist, emphasized that people should still consult a health-care professional before starting it
Nature 592 , 695703 (2021)
For some people who are no longer breastfeeding and have medical clearance, a GLP-1 may be appropriate later on, but there is no universal best option immediately after birth
#Glutathione #VitaminC #DetoxFoods #BetterBones #HealthyAging #DrSusanBrown #Antioxidants #NutritionTips #Broccoli #GarlicBenefits #NaturalHealth | Better Bones, Better Body: Osteoporosis & Osteopenia